Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Free Cash Flow Generation Index
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥227.48 Million represents 1% of operating cash flow (CN¥281.88 Million). Explore 605033 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shaanxi Meibang Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Shaanxi Meibang Pharmaceutical Group Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see Shaanxi Meibang Pharmaceutical Group Co (605033) cash conversion ratio.
Annual Free Cash Flow Generation for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for Shaanxi Meibang Pharmaceutical Group Co Ltd. Check 605033 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CN¥121.59 Million | CN¥280.40 Million | CN¥158.81 Million | ▲ +10.7% |
| 2023 | 0.39x | CN¥131.10 Million | CN¥334.79 Million | CN¥203.69 Million | ▲ +189.1% |
| 2022 | 0.14x | CN¥17.12 Million | CN¥126.41 Million | CN¥109.29 Million | ▼ -23.0% |
| 2020 | 0.18x | CN¥13.17 Million | CN¥74.88 Million | CN¥61.71 Million | ▼ -76.1% |
| 2019 | 0.74x | CN¥94.67 Million | CN¥128.45 Million | CN¥33.78 Million | ▲ +169.8% |
| 2018 | -1.06x | CN¥-17.90 Million | CN¥16.96 Million | CN¥34.86 Million | ▼ -362.1% |
| 2017 | 0.40x | CN¥11.85 Million | CN¥29.41 Million | CN¥17.56 Million | — |